In the past five years, research has found that GLP-1 drugs can lower the risk of a number of obesity-related chronic diseases such as heart disease, chronic kidney disease, sleep disorders, osteoarthritis and even certain cancers, with one study finding that people taking GLP-1 drugs had a lower risk of developing 42 different diseases than those given their usual medicines
We don't just focus on what's in the bottlewe're obsessed with what actually makes it into your cells
Avoid eye area and mucous membranes
Semaglutide (like Ozempic or Wegovy) targets GLP-1 receptors to curb appetite, leading to about 15% average weight loss
Up to 2575% of cancer patients undergoing various chemotherapy treatments experience chemotherapy-induced intestinal mucosal injury which can include diarrhea, a decline in quality of life, treatment intolerance that forces discontinuation of drugs, and even mortality (Li et al